Function Therapeutics Inc.
Milwaukee, WI
- UEI
- DMN7SCPC2TR5
- CAGE
- 982Q2
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1626 N Prospect Ave #1901, Milwaukee, WI 53202, USA
- Website
- functiontx.com
- Founded
- 2020
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Function Therapeutics Inc.
Function Therapeutics Inc. is a for-profit corporate entity based in Milwaukee, Wisconsin, registered in SAM.gov since December 2021. The company appears to be a biotechnology research firm focused on developing novel small molecule therapeutics that modulate protease-activated receptor 1 (PAR1) to address various inflammatory and disease conditions. Their research centers on a proprietary class of compounds called Parmodulins, which are designed to potentially treat complex medical conditions by influencing cellular signaling pathways, with a particular emphasis on reducing inflammation and mitigating disease progression.
The company has secured multiple federal grant awards from prestigious research agencies, including the National Institute of Neurological Disorders and Stroke, National Institute of Diabetes and Digestive and Kidney Diseases, National Heart Lung and Blood Institute, and the National Science Foundation. Their grant-funded research targets specific medical challenges such as neuropathic pain, metabolic dysfunction-associated steatohepatitis (MASH), acute kidney injury, and sickle cell disease. Each project involves systematic research approaches, including synthesizing novel Parmodulins, conducting in vitro and in vivo testing, performing drug-like profiling assays, and validating the compounds' potential therapeutic efficacy. The grants, ranging from approximately $499,863 to unspecified amounts, support comprehensive research aimed at developing innovative pharmaceutical interventions with potential applications across multiple disease domains, emphasizing the development of treatments with reduced side effects and abuse potential.
Quick answers
What is Function Therapeutics Inc.'s UEI?
Function Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is DMN7SCPC2TR5.
What is Function Therapeutics Inc.'s CAGE code?
Function Therapeutics Inc.'s CAGE code is 982Q2.
What is Function Therapeutics Inc.'s primary NAICS code?
Function Therapeutics Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Function Therapeutics Inc. located?
Function Therapeutics Inc.'s physical address in SAM.gov is 1626 N Prospect Ave #1901, Milwaukee, WI 53202, USA.
Is Function Therapeutics Inc. registered in SAM.gov?
Yes. Function Therapeutics Inc.'s SAM.gov registration is active through September 17, 2027.
What is Function Therapeutics Inc.'s most recent federal award?
Function Therapeutics Inc.'s most recent federal grant award is Parmodulins without abuse potential for the treatment of neuropathic pain - project summary neuropathic pain, a… (R43NS143450), from National Institute of Neurological Disorders and Stroke, on September 11, 2025.
On GovTribe
See Function Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors